title: Biology and clinical potential of stem-cell factor.
abstract: Stem-cell factor (SCF) is a hematopoietic growth factor that acts on both primitive and mature progenitor cells. Preclinical studies have shown that recombinant SCF can protect against lethal irradiation, elicit multilineage hematopoietic responses and increases in bone marrow cellularity, and increase the number of circulating peripheral blood progenitor cells (PBPCs) in a dose-dependent manner. Both preclinical and early clinical studies using recombinant methionyl human SCF plus recombinant methionyl human granulocyte colony-stimulating factor (Filgrastim) have demonstrated increased PBPC mobilization as compared with the use of either factor alone. These data suggest a clinical role for the combination.
authors.affiliation: UCLA School of Medicine 90024, USA.
authors.forename: J
authors.initials: J
authors.lastname: Glaspy
authors.forename: M W
authors.initials: MW
authors.lastname: Davis
authors.forename: W R
authors.initials: WR
authors.lastname: Parker
authors.forename: M
authors.initials: M
authors.lastname: Foote
authors.forename: I
authors.initials: I
authors.lastname: McNiece
mesh_terms: D000818:Animals; D018952:Antigens, CD34 / Q000502:physiology; D004357:Drug Synergism; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006412:Hematopoietic Stem Cells / Q000502:physiology*; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D019089:Stem Cell Factor / Q000502:physiology* / Q000627:therapeutic use*
chemical_list: D018952:Antigens, CD34; D011994:Recombinant Proteins; D019089:Stem Cell Factor; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim